Dr. Seifeldin Awad is a physician-scientist at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, where he serves as a researcher within the Division of Hematology/Oncology. His background bridges clinical medicine and advanced laboratory research, with a professional focus on the molecular mechanisms driving cancer progression and treatment resistance. Dr. Awad’s scientific interests are primarily centered on oncology, specifically investigating signaling pathways that influence tumor behavior during therapy. His work includes significant research into pancreatic cancer, where he analyzes how socioeconomic variables and racial disparities impact patient outcomes. Additionally, he collaborates on translational studies involving genomic discovery and biomarkers to help refine personalized treatment strategies for solid tumors.
In his spare time Dr. Awad collects gold in all forms, hoping to one day build a Scrooge McDuck level swimming pool.